APM
COLL icon

Avidity Partners Management’s Collegium Pharmaceutical COLL Stock Holding History

Avidity Partners Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-117,000
Closed -$3.77M – 86
2024
Q2 		$3.77M Sell
117,000
-244,400
-68% -$8.47M 0.16% 76
2024
Q1 		$14M Buy
361,400
+37
+0% +$1.29K 0.45% 60
2023
Q4 		$11.1M Buy
361,363
+11,163
+3% +$280K 0.41% 60
2023
Q3 		$7.83M Sell
350,200
-3,900
-1% -$88.9K 0.32% 69
2023
Q2 		$7.61M Sell
354,100
-31,400
-8% -$713K 0.27% 77
2023
Q1 		$9.25M Buy
385,500
+347,602
+917% +$9.22M 0.31% 65
2022
Q4 		$879K Buy
+37,898
New +$764K 0.02% 81
2021
Q2 		– Sell
-740,000
Closed -$17.5M – 126
2021
Q1 		$17.5M Sell
740,000
-499,000
-40% -$11.9M 0.48% 63
2020
Q4 		$24.8M Buy
1,239,000
+238,600
+24% +$4.66M 0.81% 47
2020
Q3 		$20.8M Buy
+1,000,400
New +$18.1M 0.97% 32
2020
Q2 		– Sell
-17,000
Closed -$278K – 64
2020
Q1 		$278K Sell
17,000
-163,000
-91% -$3.36M 0.04% 52
2019
Q4 		$3.7M Buy
+180,000
New +$3M 2.33% 23

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Avidity Partners Management's COLL Position: Q3 2024 in Review

Avidity Partners Management sold out of Collegium Pharmaceutical (COLL) in Q3 2024, closing a stake of 117,000 shares — an estimated $3.77M sold.

Avidity Partners Management first reported a position in COLL in Q4 2019 and held it in 12 quarters. The position peaked at $24.8M in Q4 2020. 249 funds tracked by Wall St. Rank hold COLL as of Q3 2024.

  • Avidity Partners Management reported no remaining Collegium Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Avidity Partners Management sold 117,000 Collegium Pharmaceutical shares in Q3 2024, an estimated $3.77M.
  • Avidity Partners Management first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 12 quarters.
  • Avidity Partners Management's Collegium Pharmaceutical position peaked at $24.8M in Q4 2020.
  • 249 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2024.

Based on Avidity Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.